2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS 1030825-20-7 Purity ≥98.0% (HPLC)

Short Description:

2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene

CAS: 1030825-20-7

Appearance: White or Off-White Powder

Purity: ≥98.0% (HPLC) 

Intermediate of API (CAS: 842133-18-0) in the treatment of Type 2 Diabetes Mellitus

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name 2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene
CAS Number 1030825-20-7
CAT Number RF-PI234
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C18H14BrFS
Molecular Weight 361.27
Melting Point 103℃
Density 1.388
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance White or Off-White Powder
Purity / Analysis Method  ≥98.0% (HPLC)
Loss on Drying ≤1.00%
Residue on ignition ≤0.50%
Heavy Metals ≤20ppm
Test Standard Enterprise Standard
Usage Intermediate of API (CAS: 842133-18-0)

Package & Storage:

Package: Bottle, Aluminum foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light & moisture

Advantages:

1

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene (CAS: 1030825-20-7) with high quality. It is an intermediate typically in the synthesis of API (CAS: 461432-26-8). API (CAS: 461432-26-8) is a new antidiabetic drug jointly developed by Bristol-Myers Squibb and AstraZeneca, being approved by the European Medicines Agency (EMA) on November 12, 2012. It is also the first approved SGLT2 inhibitor for the treatment of type II diabetes, being an important option in the treatment of diabetes, and is used to improve glycemic control as an adjunct to dietary and exercise for adults with type II diabetes.

  • Write your message here and send it to us